New Funding Opportunities Available for Collaborative Rare Diseases Research
On June 11, 2018, NCATS announced two new Rare Diseases Clinical Research Network (RDCRN) program funding opportunities to support collaborative clinical research on rare diseases. The Center is accepting applications for Rare Diseases Clinical Research Consortia and a Data Management and Coordinating Center (DMCC); both funding opportunities have a deadline of Oct. 9, 2018. More information can be found here.
Clinical and Translational Science Award (U54 Clinical Trial Optional)
On September 27, 2018, NIH announced new funding opportunity. The project period is limited to five years starting from December 25, 2018. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in the Clinical and Translational Science Award (CTSA) Program which supports high quality translational science and clinical research locally, regionally and nationally and fosters innovation in research methods, training, and career development. More information can be found here.Back to News List